Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 8
1947 20
1948 19
1949 14
1950 24
1951 19
1952 25
1953 19
1954 21
1955 28
1956 20
1957 23
1958 30
1959 28
1960 33
1961 43
1962 77
1963 158
1964 236
1965 219
1966 238
1967 257
1968 341
1969 417
1970 458
1971 498
1972 513
1973 538
1974 564
1975 411
1976 350
1977 357
1978 263
1979 267
1980 246
1981 194
1982 203
1983 195
1984 208
1985 242
1986 200
1987 203
1988 237
1989 255
1990 313
1991 308
1992 284
1993 341
1994 372
1995 386
1996 405
1997 419
1998 480
1999 441
2000 585
2001 627
2002 640
2003 709
2004 721
2005 698
2006 630
2007 633
2008 571
2009 539
2010 479
2011 510
2012 483
2013 493
2014 475
2015 429
2016 399
2017 386
2018 403
2019 366
2020 820
2021 869
2022 757
2023 375
2024 518
2025 265

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,464 results

Results by year

Filters applied: . Clear all
Page 1
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
Esser S, Brunetta J, Inciarte A, Levy I, D'Arminio Monforte A, Lambert JS, van Welzen B, Teruya K, Boffito M, Liu CE, Altuntas Aydın O, Thorpe D, Heinzkill M, Marongiu A, Cassidy T, Haubrich R, D'Amato L, Robineau O. Esser S, et al. HIV Med. 2024 Apr;25(4):440-453. doi: 10.1111/hiv.13593. Epub 2023 Dec 26. HIV Med. 2024. PMID: 38148567
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Spinner CD, et al. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349. JAMA. 2020. PMID: 32821939 Free PMC article. Clinical Trial.
Emerging SARS-CoV-2 Resistance After Antiviral Treatment.
Tamura TJ, Choudhary MC, Deo R, Yousuf F, Gomez AN, Edelstein GE, Boucau J, Glover OT, Barry M, Gilbert RF, Reynolds Z, Li Y, Tien D, Vyas TD, Passell E, Su K, Drapkin S, Abar EG, Kawano Y, Sparks JA, Wallace ZS, Vyas JM, Shafer RW, Siedner MJ, Barczak AK, Lemieux JE, Li JZ; POSITIVES Study Team. Tamura TJ, et al. JAMA Netw Open. 2024 Sep 3;7(9):e2435431. doi: 10.1001/jamanetworkopen.2024.35431. JAMA Netw Open. 2024. PMID: 39320890 Free PMC article.
Effect of alanine supplementation on oxalate synthesis.
Wood KD, Freeman BL, Killian ME, Lai WS, Assimos D, Knight J, Fargue S. Wood KD, et al. Biochim Biophys Acta Mol Basis Dis. 2021 Jan 1;1867(1):165981. doi: 10.1016/j.bbadis.2020.165981. Epub 2020 Sep 28. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33002578 Free PMC article.
Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study.
Janssen HLA, Lim YS, Lampertico P, Heo J, Chen CY, Fournier C, Tsang TYO, Bae H, Chen CH, Coffin CS, Ahn SH, Trinh H, Flaherty JF, Abramov F, Zhao Y, Liu Y, Lau A, German P, Chuang WL, Agarwal K, Gane E. Janssen HLA, et al. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):718-733. doi: 10.1016/S2468-1253(24)00096-7. Epub 2024 Jun 17. Lancet Gastroenterol Hepatol. 2024. PMID: 38901444 Clinical Trial.
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.
Buti M, Lim YS, Chan HLY, Agarwal K, Marcellin P, Brunetto MR, Chuang WL, Janssen HLA, Fung SK, Izumi N, Jablkowski MS, Abdurakhmanov D, Abramov F, Wang H, Botros I, Yee LJ, Mateo R, Flaherty JF, Osinusi A, Pan CQ, Shalimar X, Seto WK, Gane EJ. Buti M, et al. Aliment Pharmacol Ther. 2024 Dec;60(11-12):1573-1586. doi: 10.1111/apt.18278. Epub 2024 Sep 27. Aliment Pharmacol Ther. 2024. PMID: 39327857 Free PMC article. Clinical Trial.
Will There Be a Cure for Ebola?
Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S. Cardile AP, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:329-348. doi: 10.1146/annurev-pharmtox-010716-105055. Epub 2016 Dec 7. Annu Rev Pharmacol Toxicol. 2017. PMID: 27959624 Review.
Advances in SARS-CoV-2: a systematic review.
Bai YX, Xu YH, Wang X, Sun C, Guo Y, Qiu S, Ma KW. Bai YX, et al. Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9208-9215. doi: 10.26355/eurrev_202009_22873. Eur Rev Med Pharmacol Sci. 2020. PMID: 32965016 Free article.
25,464 results
You have reached the last available page of results. Please see the User Guide for more information.